APA (7th ed.) Citation

U, E., M, B., M, A., K, B., B, L., & B, D. (1999). Rosiglitazone (BRL49653), a PPARgamma-selective agonist, causes peroxisome proliferator-like liver effects in obese mice. Journal of lipid research, 40(7), 1177.

Chicago Style (17th ed.) Citation

U, Edvardsson, Bergström M, Alexandersson M, Bamberg K, Ljung B, and Dahllöf B. "Rosiglitazone (BRL49653), a PPARgamma-selective Agonist, Causes Peroxisome Proliferator-like Liver Effects in Obese Mice." Journal of Lipid Research 40, no. 7 (1999): 1177.

MLA (9th ed.) Citation

U, Edvardsson, et al. "Rosiglitazone (BRL49653), a PPARgamma-selective Agonist, Causes Peroxisome Proliferator-like Liver Effects in Obese Mice." Journal of Lipid Research, vol. 40, no. 7, 1999, p. 1177.